The short version

From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.

  • Hinge Health is the larger company, worth $8.1B, about 1.5 times MiniMed.
  • Hinge Health grew revenue faster over the last year (+53.0% vs +16.6%).

Side by side

The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.

MeasureHNGEMMED
Market cap$8.1B$5.5B
Share price$102.90$19.71
Revenue (last fiscal year)$588M$3.1B
Free cash flow (last fiscal year)$165M-$420M
Revenue growth, last year+53.0%+16.6%
Revenue growth per year, last 5 fiscal years+41.7%+12.1%
Operating margin13.0%—
Net margin15.2%—
Return on equity31.7%-8.5%
P/E (trailing)——
Price / free cash flow47.2x—
EV / EBITDA68.7x72.3x
FCF growth the price implies16.7%—
Dividend yield——
Debt / equity1.40x0.30x
Fundamental gradeCD
Superinvestors holding it40
Insider purchases, last 12 months00

Results from SEC filings

Revenue and free cash flow by fiscal year, from each company's 10-K filings.

Hinge Health

YearRevenueFree cash flowOp. margin
2023$293M-$69M-44.6%
2024$390M$45M-8.2%
2025$588M$165M-92.9%

MiniMed

YearRevenueFree cash flowOp. margin
2024$2.5B-$107M-2.8%
2025$2.7B-$53M-5.4%
2026$3.1B-$420M-6.1%

Where the revenue comes from

Hinge Health

No segment breakdown reported.

MiniMed · by products, 2026

CGM$1.6B50%
Consumables$956M31%
Pumps$546M18%
Other$46M1%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open HNGE in Investingly

Questions

Which is bigger, Hinge Health or MiniMed?

Hinge Health (HNGE), at $8.1B against $5.5B.

Which grows faster, HNGE or MMED?

Hinge Health: revenue grew +53.0% over the last year, against +16.6%.

Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.